Acute Management: Intravenous Immunoglobulin or Plasma Exchange
This patient with bilateral lower limb weakness (2/5 strength) and absent plantar reflexes requires immediate treatment with either intravenous immunoglobulin (IVIG) 0.4 g/kg daily for 5 days OR plasma exchange (200-250 ml/kg for 5 sessions), as this presentation is highly consistent with Guillain-Barré syndrome (GBS). 1
Clinical Reasoning
The clinical picture strongly suggests GBS based on:
- Bilateral progressive weakness starting in the lower limbs
- Absent reflexes (areflexia) in affected limbs
- Absence of respiratory or facial involvement (yet), which is typical early in the disease course
- Time course consistent with GBS (progressive phase typically lasts days to 4 weeks, usually <2 weeks) 1
The absent plantar reflexes are particularly important—this indicates lower motor neuron involvement, which is characteristic of GBS. While extensor plantar responses would cast doubt on the diagnosis, absent reflexes strongly support it 1, 2.
Immediate Treatment Protocol
First-Line Immunotherapy (Choose ONE):
Option 1: Intravenous Immunoglobulin (IVIG)
- Dose: 0.4 g/kg/day for 5 consecutive days 1
- Preferred in most centers due to ease of administration
- Multiple case reports demonstrate significant improvement with IVIG 2, 3, 4, 5, 6
Option 2: Plasma Exchange
- Dose: 200-250 ml/kg total volume over 5 sessions 1
- Equally effective as IVIG
- May be preferred if IVIG contraindicated
Critical: Do NOT use corticosteroids—one case report showed initial worsening with corticosteroid therapy before improvement with IVIG 2.
Diagnostic Confirmation (Parallel to Treatment)
While treatment should not be delayed, obtain:
- Lumbar puncture: Look for albuminocytological dissociation (elevated CSF protein >60 mg/dL with normal white cell count) 2, 3, 4, 5
- Nerve conduction studies: May show demyelinating polyneuropathy, but can be normal in first week 1, 7
Critical Monitoring Requirements
Respiratory function monitoring is essential even without current respiratory symptoms:
- Serial vital capacity measurements
- Negative inspiratory force
- Oxygen saturation
- Watch for signs of impending respiratory failure (disease typically reaches maximum disability within 2 weeks) 1
Autonomic monitoring:
- Blood pressure instability
- Heart rate variability
- Cardiac monitoring 1
Important Caveats
Features That Support GBS Diagnosis:
- Progressive phase from days to 4 weeks 1
- Relative symmetry (though can be asymmetrical) 1
- Pain (muscular, radicular, or neuropathic) is common 1, 4, 5
Red Flags Suggesting Alternative Diagnosis:
- Fever at onset 1
- Marked persistent asymmetry 1
- Bladder/bowel dysfunction at onset 1
- Sharp sensory level (suggests spinal cord pathology) 1
- Hyperreflexia or extensor plantar responses 1
- Nadir reached in <24 hours 1
Differential Considerations:
Given absent plantar reflexes and bilateral lower limb weakness, also consider:
- Acute vascular events (though typically more sudden onset) 8
- Spinal cord pathology (but absent reflexes argue against this) 9
- Other polyradiculopathies (infectious causes) 1
Prognosis and Follow-up
- Recovery can continue for >3 years after onset 1
- Recurrence is rare (2-5%) 1
- Early neurorehabilitation improves outcomes 3, 5
- Calculate modified Erasmus GBS Outcome Score (mEGOS) on admission for prognostication 1
The key is not to delay treatment while awaiting confirmatory tests—clinical diagnosis is sufficient to initiate IVIG or plasma exchange, as both electrodiagnostic studies and CSF analysis may be normal early in the disease course 1.